What is the normal range and clinical significance of interventricular septal thickness in diastole (IVSd) on a 2‑dimensional echocardiogram?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal Range for Interventricular Septal Thickness in Diastole (IVSd)

The normal range for interventricular septal thickness in diastole on 2D echocardiography is 0.6–0.9 cm in women and 0.6–1.0 cm in men, with values ≥1.1 cm in women or ≥1.2 cm in men indicating left ventricular hypertrophy. 1

Gender-Specific Reference Values

The ASE/EACVI guidelines provide clear cutoffs based on the linear measurement method:

  • Women: 6–9 mm (normal range)
  • Men: 6–10 mm (normal range)

Values exceeding these ranges suggest pathologic hypertrophy rather than normal variation 1.

Clinical Significance and Interpretation

Age-Related Considerations

IVSd thickness increases physiologically with age, which is critical for accurate interpretation. The interventricular septum increases from a median of 8.3 mm in patients aged 20–29 years to 11.2 mm in those aged 60–70 years 2. This means a septal thickness of 10 mm may be normal in a 65-year-old but abnormal in a 25-year-old.

Body Surface Area Indexing

Always index measurements to body surface area (BSA) to avoid misclassification, particularly in patients at extremes of height or weight 1, 3. This is especially important in:

  • Athletes (particularly football linemen who may have BSA-related physiologic increases) 4
  • Obese patients
  • Very tall or short individuals

Pathologic Implications

Increased IVSd thickness has significant prognostic implications:

  • Hypertension: Even IVS thickening within the "normal range" correlates with higher systolic blood pressure and may warrant closer BP monitoring 5
  • Left ventricular hypertrophy: When combined with posterior wall thickness and relative wall thickness (RWT), allows categorization as:
    • Concentric hypertrophy (RWT >0.42)
    • Eccentric hypertrophy (RWT ≤0.42)
    • Concentric remodeling (normal LV mass with RWT >0.42) 1

Measurement Technique Matters

2D echocardiography measurements are systematically higher than M-mode measurements (average difference 0.8 mm), so reference values must match the measurement technique used 6. When measuring IVSd:

  • Measure at end-diastole (at the Q wave on ECG)
  • Use the same technique for serial measurements in individual patients
  • In asymmetric septal hypertrophy, document the location and maximal thickness 3

Special Clinical Scenarios

Cardiac Amyloidosis

The ratio of IVSd to global longitudinal strain (GLS) is highly discriminatory for cardiac amyloidosis. An IVSd/GLS ratio >0.15 has 70% sensitivity and 80% specificity for identifying cardiac amyloidosis in patients with increased LV wall thickness 7.

Hypertrophic Cardiomyopathy

In patients with asymmetric hypertrophy, 3D echocardiography should be preferred over linear measurements because it accommodates regional differences in wall thickness and provides more accurate assessment 1, 3. Linear methods overestimate LV mass when the thickest septal region is at the base.

Common Pitfalls to Avoid

  1. Failing to account for age: Using a single cutoff across all ages leads to overdiagnosis in elderly patients and underdiagnosis in young patients
  2. Not indexing to BSA: Particularly problematic in athletes and obese patients
  3. Mixing measurement techniques: M-mode and 2D values are not interchangeable
  4. Ignoring clinical context: Isolated mild IVS thickening (10–11 mm) in a hypertensive patient may be significant even if technically "normal"

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.